Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a study to see whether radiotherapy plus chemotherapy (Temozolomide) plus
Dichloroacetate (DCA) improves overall survival and offers better control of the disease in
patients with newly diagnosed Glioblastoma Multiforme Tumours.